scispace - formally typeset
W

Wen-Cai Ye

Researcher at Jinan University

Publications -  551
Citations -  10678

Wen-Cai Ye is an academic researcher from Jinan University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 41, co-authored 485 publications receiving 7917 citations. Previous affiliations of Wen-Cai Ye include Chinese Ministry of Education & Second Military Medical University.

Papers
More filters
Journal ArticleDOI

Phenolic compounds from Origanum vulgare and their antioxidant and antiviral activities

TL;DR: Six new phenolic compounds along with five known ones were isolated from the ethanol extract of the whole plants of Origanum vulgare, and two new compounds exhibited significant antioxidant activity comparable to that of ascorbic acid.
Journal ArticleDOI

Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro.

TL;DR: AL-1 showed significant activity against influenza A viruses including the H5N1 avian influenza virus, and may warrant further evaluation as a possible therapy for influenza.
Journal ArticleDOI

Isolation and biological properties of polysaccharide CPS-1 from cultured Cordyceps militaris

TL;DR: CPS-1 was shown to possess a significant antiinflammatory activity and suppressed the humoral immunity in mice but had no significant effects on the cellular immunity and the non-specific immunity.
Journal ArticleDOI

Psiguadials A and B, two novel meroterpenoids with unusual skeletons from the leaves of Psidium guajava.

TL;DR: Psiguadials A and B, two novel sesquiterpenoid-diphenylmethane meroterpenoids with unusual skeletons, along with a pair of known epimers, psidial A and guajadial, were isolated from the leaves of Psidium guajava and exhibited potent inhibitory effects on the growth of human hepatoma cells.
Journal ArticleDOI

Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis.

TL;DR: In vivo study showed that bufotalin significantly inhibited the growth of xenografted R-HepG2 cells, without body weight loss or marked toxicity towards the spleen, indicating thatbufotalin has a promising potential to become a novel anti-cancer agent for the treatment of liver cancer with multidrug resistance.